03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Viramune Tablets° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Boehringer Ingelheim |
Manufacturer | Boehringer Ingelheim Pharma GmbH & Co KG |
Origin | Germany |
ATC | J05AG01 |
Viramune Tablets° :
Viramune Tablets° :
Viramune Tablets° :
Viramune Tablets° :
Viramune Tablets° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
ALT increased | Common |
Anaemia | Uncommon |
Anaphylactic reactions | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Common |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
AST increased | Common |
Autoimmune disorder | Not known |
Basedow's disease | Not known |
Blood alkaline phosphatase increased | Not known |
Blood bilirubin increased | Not known |
Blood phosphorus decreased | Uncommon |
Blood pressure increased | Uncommon |
Body fat disorder | Not known |
Breast enlargement | Not known |
Diarrhoea (Diarrhea) | Common |
DRESS (Drug reaction with eosinophilia and systemic symptoms) | Uncommon |
Eosinophilia | Not known |
Facial wasting | Not known |
Fat redistribution | Not known |
Fatigue | Common |
Gamma-GT increased | Common |
Granulocytopenia | Common |
Headache | Common |
Hepatic enzyme increased | Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatitis | Common |
Hepatitis fulminant | Rare |
Hepatorenal failure | Rare |
Hepatotoxicity (liver toxicity) | Common |
Hypercholesterolaemia | Not known |
Hyperglycaemia | Not known |
Hyperlactacidaemia | Not known |
Hypersensitivity | Common |
Hypertransaminasaemia | Common |
Hypertriglyceridaemia | Not known |
Immune reconstitution inflammatory syndrome | Not known |
Insulin resistance | Not known |
Jaundice | Uncommon |
Lipodystrophy acquired | Not known |
Lipohypertrophy | Not known |
Liver function test abnormal | Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Uncommon |
Lymphadenopathy | Not known |
Maculopapular rash | Not known |
Myalgia | Common |
Nausea | Common |
Neuropathy peripheral | Not known |
Osteonecrosis | Not known |
Pancreatitis | Not known |
Pyrexia | Common |
Renal impairment | Not known |
Skin rash | Very Common |
Stevens-Johnson syndrome | Uncommon |
Thrombocytopenia (Thrombopenia) | Not known |
Transaminases increased | Common |
Urticaria | Common |
Vomiting | Common |
NB : Products With Same Indication |
Different Units By MoH Code
Viramune Tablets° MoH 2371 :
Form | Tablet |
Package Size | Box of 60 |
Strength | 200mg |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 405980/00 |
Submission date | 01/01/2000 |
Registration Year | 2000 |
Withdrawn Date | 2011 |
Price Comparison
You have to register to view this info
Drop File